Centers for Disease Control and Prevention

Description

CDC Cambodia has partnered directly with the National Center for Tuberculosis and Leprosy Control (CENAT) since 2009 through a cooperative agreement to diagnose tuberculosis (TB) in HIV-positive patients and detect multi-drug resistant TB. In this follow-on funding opportunity, the national tuberculosis control program will scale-up, monitor, and supervise national TB/HIV activities, in coordination with the National Center for HIV/AIDS, Dermatology, and STDs (NCHADS). The objectives are to achieve and sustain nationwide scale up of the “Three Is” (intensified case finding [ICF], isoniazid preventive therapy, and infection control) and rapid, early treatment of co-infected patients with both antiretroviral and anti-tuberculosis regimens. To promote long-term sustainability, the cooperative agreement will foster monitoring and evaluation systems and strengthen the capacity of national health care staff to correctly diagnose and treat TB using evidence-based, cost-effective TB diagnostic algorithms.

Who can apply

• Others

Contact

CDC Procurement and Grants Office <br/>Technical Information Management Section <br/>E-mail: pgotim@cdc.gov <br/>Phone: 770-488-2700 <br/>
pgotim@cdc.gov